Evaluation of anti-depressant-like activity of linezolid, an oxazolidinone class derivative - An investigation using behavioral tests battery of depression

Biochemical and Biophysical Research Communications

Volumn 409, Issue 4, 2011, Pages 723-726

  Mahesh, Radhakrishnan ^a   Jindal, Ankur ^a   Gautam, Baldev ^a   Bhatt, Shvetank ^a   Pandey, Dilip ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Anti depressant; Behavioral test; Linezolid; Monoamine oxidase inhibitor

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMFEBUTAMONE; FLUOXETINE; LINEZOLID; PARGYLINE; RESERPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG POTENTIATION; DRUG SCREENING; FORCED SWIMMING TEST; HEAD TWITCH; HYPOTHERMIA; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

5-HYDROXYTRYPTOPHAN; ACETAMIDES; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HYPOTHERMIA; MALE; MICE; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; OXAZOLIDINONES; RATS; RATS, WISTAR; RESERPINE;

ANIMALIA; MUS; RATTUS; RODENTIA;

EID: 79959207311     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.05.075     Document Type: Article

References (28)

1. Nemeroff C.B. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J. Psychiat. Res. 2007, 41:189-206.
2. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:593-602.
3. Manji H.K., Drevets W.C., Charney D.S. The cellular neurobiology of depression. Nat. Med. 2001, 7:541-547.
4. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:3413-3425.
5. Tremblay P., Blier P. Catecholaminergic strategies for the treatment of major depression. Curr. Drug Targets 2006, 7:149-158.
6. Schildkraut J.J., Kety S.S. Biogenic amines and emotion. Science 1967, 156:21-37.
7. Millan M.J. Multi-target strategies for the improved treatment of depressive states: conceptual foundations neuronal substrates, drug discovery and therapeutic application. Pharmacol. Ther. 2006, 110:135-370.
8. Bortolato M., Chen K., Shih J.C. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv. Drug Deliv. Rev. 2008, 60:1527-1533.
9. Youdim M.B.H., Bakhle Y.S. Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness. Br. J. Pharmacol. 2006, 147:S287-S296.
10. Johnston P. Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem. Pharmacol. 1968, 17:1285-1297.
11. Ament P.W., Jamshed N., Horne J.P. Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections. Am. Fam. Physician 2002, 65:663-670.
12. Mai A., Artico M., Esposito M., Ragno R., Sbardella G., Massa S. Synthesis and biological evaluation of enantiomerically pure pyrrolyloxazolidinones as a new class of potent and selective monoamine oxidase type A inhibitors. Farmaco 2003, 58:231-241.
13. Reck F., Zhou F., Girardot M., Kern G., Eyermann C.J., Hales N.J., Ramsay R.R., Gravestock M.B. Identification of 4-substituted 1, 2, 3-triazoles as novel oxazolidinone antibacterial agents with reduced activity against monoamine oxidase A. J. Med. Chem. 2005, 48:499-506.
14. Boissier J.R., Simon P. Action of caffeine on the spontaneous motility of the mouse. Arch. Int. Pharmacodyn. Ther. 1965, 158:212-221.
15. Porsolt R.D., Bertin A., Jalfre M. Behavioural despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 1977, 229:327-336.
16. Mahesh R., Rajkumar R., Minasri B., Perumal R.V. Potential antidepressants: pharmacology of 2-(4-methylpiperazin-1-yl)-1-8-naphthyridine-3-carbonitrile in rodent behavioral models. Pharmazie 2007, 60:919-924.
17. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85:367-370.
18. Martin P., Massol J., Soubrie P., Puech A.J. Effects of triiodothyronine (T3) on the potentiation by antidepressants of L-5-hydroxytryptophan-induced head-twitches in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 1989, 13:735-748.
19. Devadoss T., Pandey D.K., Mahesh R., Yadav S.K. Effect of acute chronic treatment with QCF-3 (4-benzylpiperazin-1-yl) (quinoxalin-2-yl) methanone a novel 5-HT3 receptor antagonist in animal models of depression. Pharmacol. Reports 2010, 62:245-257.
20. Umathe S.N., Bhutada P.S., Jain N.S., Shukla N.R., Mundhada Y.R., Dixit P.V. Gonadotropin-releasing hormone agonist blocks anxiogenic-like and depressant-like effect of corticotrophin-releasing hormone in mice. Neuropeptides 2008, 42:399-410.
21. Pandey D.K., Ramamoorthy R., Mahesh R., Radha R. Depressant-like effects of parthenolide in rodent behavioural anti-depressant test battery. J. Pharm. Pharmacol. 2008, 60:1643-1650.
22. Borsini F. Role of serotonergic system in the forced swimming test. Neurosci. Biobehav. Rev. 1995, 19:377-395.
23. Cases O., Seif I., Grimsby J., Gaspar P., Chen K., Pournin S., Muller U., Aguet M., Babinet C., Shih J.C. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAO-A. Science 1995, 268:1763-1766.
24. Lucki I. The spectrum of behaviors influenced by serotonin. Biol. Psychiatry 1998, 44:151-162.
25. Scott A.L., Bortolato M., Chen K., Shih J.C. Novel monoamine oxidase a knock out mice with human-like spontaneous mutation. Neuroreport 2008, 19:739-743.
26. Ortmann R., Martin S., Radeke E., Stula A.D. Interaction of beta-adrenoreceptor agonists with the serotonergic system in rat brain. A behavioural study using the L-5-HTP syndrome. Naunyn. Schmiedebergs Arch. Pharmacol. 1981, 316:225-230.
27. Quinn D.K., Stern T.A. Linezolid and serotonin syndrome prim. care companion. J. Clin. Psychiatry 2009, 11:353-356.
28. Englert L.F., Ho B.T., Taylor D. The effects of (-)-deltatetrahydrocannabinol on reserpine-induced hypothermia in rats. Br. J. Pharmacol. 1973, 49:243-252.